NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 3PTZ designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 3PTZ_NAD_A_500 | 69% | 5% | 0.154 | 0.974 | 2.58 | 2.7 | 8 | 16 | 12 | 0 | 100% | 1 |
| 3PTZ_NAD_B_500 | 64% | 2% | 0.164 | 0.967 | 3.18 | 3.14 | 9 | 18 | 21 | 0 | 100% | 1 |
| 3PTZ_NAD_E_500 | 63% | 5% | 0.164 | 0.963 | 3.02 | 2.19 | 8 | 12 | 11 | 0 | 100% | 1 |
| 3PTZ_NAD_F_500 | 62% | 6% | 0.165 | 0.961 | 2.57 | 2.35 | 8 | 15 | 14 | 0 | 100% | 1 |
| 3PTZ_NAD_D_500 | 58% | 9% | 0.166 | 0.949 | 2.42 | 1.99 | 8 | 11 | 10 | 0 | 100% | 1 |
| 3PTZ_NAD_C_500 | 53% | 9% | 0.184 | 0.95 | 2.37 | 2 | 9 | 16 | 13 | 0 | 100% | 1 |
| 2QG4_NAD_D_500 | 97% | 26% | 0.06 | 0.988 | 1.71 | 1.22 | 4 | 4 | 0 | 0 | 100% | 1 |
| 6C4J_NAD_F_501 | 72% | 19% | 0.15 | 0.979 | 1.74 | 1.62 | 7 | 4 | 3 | 0 | 100% | 1 |
| 3TDK_NAD_H_500 | 52% | 30% | 0.172 | 0.969 | 1.2 | 1.49 | 3 | 8 | 1 | 0 | 80% | 1 |
| 9QJ0_NAD_A_501 | 100% | 67% | 0.015 | 0.999 | 0.55 | 0.55 | - | 1 | 2 | 0 | 100% | 1 |
| 3CMC_NAD_R_408 | 100% | 19% | 0.016 | 0.998 | 1.63 | 1.74 | 4 | 9 | 0 | 0 | 100% | 1 |
| 4RQU_NAD_B_403 | 100% | 3% | 0.019 | 0.997 | 3.51 | 2.61 | 13 | 18 | 0 | 0 | 100% | 1 |
| 9QJ1_NAD_J_501 | 100% | 67% | 0.022 | 0.996 | 0.55 | 0.57 | - | 1 | 5 | 0 | 100% | 1 |
| 2O2Y_NAD_C_750 | 100% | 22% | 0.023 | 0.995 | 1.7 | 1.48 | 3 | 5 | 0 | 0 | 100% | 1 |